Skip to main content
SpringerLink
Log in

Inflammatory Disorders with Unique Clinical Features

  • Chapter
  • First Online:
Skin of Color

Abstract

This chapter reviews the differential diagnosis, histopathology, treatment, etiology, epidemiology, laboratory studies, and pathophysiology of a number of inflammatory disorders with unique clinical features and their particular manifestations in skin of color. Among these disorders are atopic dermatitis, lichen planus, lupus erythematosus, pityriasis rosea, psoriasis, sarcoidosis, scleroderma, seborrheic dermatitis, syphilis, tinea versicolor, and white spot parapsoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rosen T, Orengo IF, Koff AB, Schell BJ. Clinical dermatology in black patients. Bari: Pigreco; 1995.

    Google Scholar 

  2. Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009;122:121–5.

    Article  PubMed  Google Scholar 

  3. Nnoruka EN. Current epidemiology of atopic dermatitis in South-Eastern Nigeria. Int J Dermatol. 2004;43:739–44.

    Article  PubMed  Google Scholar 

  4. Dhar S, Kanwar AJ. Epidemiology and clinical pattern of atopic dermatitis in a North Indian pediatric population. Pediatr Dermatol. 1998;15:347–51.

    Article  PubMed  CAS  Google Scholar 

  5. Lee HJ, Cho SH, Ha SJ, et al. Minor cutaneous features of atopic dermatitis in South Korea. Int J Dermatol. 2000;39:337–42.

    Article  PubMed  CAS  Google Scholar 

  6. Allen HB, Jones NP, Bowen SE. Lichenoid and other clinical presentations of atopic dermatitis in an inner city practice. J Am Acad Dermatol. 2008;58:503–4.

    Article  PubMed  Google Scholar 

  7. Summey BT, Bowen SE, Allen HB. Lichen planus-like atopic dermatitis: expanding the differential diagnosis of spongiotic dermatitis. J Cutan Pathol. 2008;35:311–4.

    Article  PubMed  Google Scholar 

  8. Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147:920–5.

    Article  PubMed  CAS  Google Scholar 

  9. Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol. 1983;1:157–64.

    Article  PubMed  CAS  Google Scholar 

  10. Lee CS, Lim HW. Cutaneous diseases in Asians. Dermatol Clin. 2003;21:669–77.

    Article  PubMed  Google Scholar 

  11. Bonness S, Bieber T. Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2007;7:382–6.

    Article  PubMed  CAS  Google Scholar 

  12. Allam JP, Novak N. The pathophysiology of atopic eczema. Clin Exp Dermatol. 2006;31:89–93.

    Article  PubMed  Google Scholar 

  13. Peterson JD, Chan LS. A comprehensive management guide for atopic dermatitis. Dermatol Nurs. 2006;18:531–42.

    PubMed  Google Scholar 

  14. Katta R. Lichen planus. Am Fam Physician. 2000;61:3319–24.

    PubMed  CAS  Google Scholar 

  15. Ellgehausen P, Elsner P, Burg G. Drug-induced lichen planus. Clin Dermatol. 1998;16:325–32.

    Article  PubMed  CAS  Google Scholar 

  16. Nnoruka EN. Lichen planus in African children: a study of 13 patients. Pediatr Dermatol. 2007;24:495–8.

    Article  PubMed  Google Scholar 

  17. Marshman G. Lichen planus. Australas J Dermatol. 1998;39:1–11.

    Article  PubMed  CAS  Google Scholar 

  18. Boyd AS. New and emerging therapies for lichenoid dermatoses. Dermatol Clin. 2000;18:21–9.

    Article  PubMed  CAS  Google Scholar 

  19. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–14.

    Article  PubMed  Google Scholar 

  20. Alam F, Hamburger J. Oral mucosal lichen planus in children. Int J Paediatr Dent. 2001;11:209–14.

    Article  PubMed  CAS  Google Scholar 

  21. Sontheimer RD. Lichenoid tissue reaction/interface dermatitis: clinical and histological ­perspectives. J Invest Dermatol. 2009;129:1088–99.

    Article  PubMed  CAS  Google Scholar 

  22. Nagao Y, Sata M. Hepatitis C virus and lichen planus. J Gastroenterol Hepatol. 2004;19:1101–13.

    Article  PubMed  Google Scholar 

  23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271–7.

    Article  PubMed  CAS  Google Scholar 

  24. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

    Article  PubMed  CAS  Google Scholar 

  25. McCauliffe DP. Cutaneous lupus erythematosus. Semin Cutan Med Surg. 2001;20:14–26.

    Article  PubMed  CAS  Google Scholar 

  26. Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24:348–62.

    Article  PubMed  Google Scholar 

  27. Martin S, Rosen T, Locker E. Metastatic squamous cell carcinoma of the lip. Occurrence in blacks with discoid lupus erythematosus. Arch Dermatol. 1979;115:1214.

    Article  PubMed  CAS  Google Scholar 

  28. Fabbri P, Cardinali C, Giomi B, et al. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003;4:449–65.

    Article  PubMed  Google Scholar 

  29. Tikly M, Burgin S, Mohanlal P, Bellingan A, George J. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol. 1996;15:261–5.

    Article  PubMed  CAS  Google Scholar 

  30. Nath SK, Namjou B, Kilpatrick J, et al. A candidate region on 11p13 for systemic lupus erythematosus: a linkage identified in African-American families. J Investig Dermatol Symp Proc. 2004;9:64–7.

    Article  PubMed  Google Scholar 

  31. González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol. 2005;44:757–64.

    Article  PubMed  Google Scholar 

  32. Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician. 2004;69:87–91.

    PubMed  Google Scholar 

  33. Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the “classic” description? Arch Pediatr Adolesc Med. 2007;161:503–6.

    Article  PubMed  Google Scholar 

  34. Chuh A, Chan H, Zawar V. Pityriasis rosea–evidence for and against an infectious aetiology. Epidemiol Infect. 2004;132:381–90.

    Article  PubMed  CAS  Google Scholar 

  35. Kempf W, Burg G. Pityriasis rosea–a virus-induced skin disease? An update. Arch Virol. 2000;145:1509–20.

    Article  PubMed  CAS  Google Scholar 

  36. Canpolat Kirac B, Adisen E, Bozdayi G, Yucel A, Fidan I, Aksakal N, et al. The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J Eur Acad Dermatol Venereol. 2009;23:16–21.

    Article  PubMed  CAS  Google Scholar 

  37. Wolff K, Johnson RA. Psoriasis. In: Sydor AM, Englis MR, editors. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 6th ed. New York: McGraw-Hill; 2009. p. 53–71.

    Google Scholar 

  38. Leder RO, Farber EM. The variable incidence of psoriasis in sub-Saharan Africa. Int J Dermatol. 1997;36:911–9.

    Article  PubMed  CAS  Google Scholar 

  39. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004;151:3–15.

    Article  PubMed  CAS  Google Scholar 

  40. Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.

    Article  PubMed  Google Scholar 

  41. Nograles KE, Brasington RD, Bowcock AM. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol. 2009;5:83–91.

    Article  PubMed  CAS  Google Scholar 

  42. Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol. 2007;33:45–56.

    Article  PubMed  CAS  Google Scholar 

  43. Gottlieb AB. Therapeutic options in the treatment of psoriasis and atopic dermatitis. J Am Acad Dermatol. 2005;53:S3–16.

    Article  PubMed  Google Scholar 

  44. Lebwohl M. A clinician’s paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53:S59–69.

    Article  PubMed  Google Scholar 

  45. Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs. 2008;68: 1361–83.

    Article  PubMed  CAS  Google Scholar 

  46. Tchernev G. Cutaneous sarcoidosis: the “great imitator”: etiopathogenesis, morphology, ­differential diagnosis, and clinical management. Am J Clin Dermatol. 2006;7:375–82.

    Article  PubMed  Google Scholar 

  47. Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician. 2002;65:1581–4.

    PubMed  Google Scholar 

  48. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224–34.

    Article  PubMed  CAS  Google Scholar 

  49. Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol. 2007;25:276–87.

    Article  PubMed  Google Scholar 

  50. Jacyk WK. Cutaneous sarcoidosis in black South Africans. Int J Dermatol. 1999;38:841–5.

    Article  PubMed  CAS  Google Scholar 

  51. Chong WS, Tan HH, Tan SH. Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Exp Dermatol. 2005;30:120–4.

    Article  PubMed  Google Scholar 

  52. Costabel U, Guzman J, Baughman RP. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol. 2007;25:303–11.

    Article  PubMed  Google Scholar 

  53. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol. 2006;54:55–60.

    Article  PubMed  Google Scholar 

  54. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med. 2008;29:365–77.

    Article  PubMed  CAS  Google Scholar 

  55. Marcoval J, Moreno A, Mañá J, Peyri J. Subcutaneous sarcoidosis. Dermatol Clin. 2008;26:553–6.

    Article  PubMed  Google Scholar 

  56. Katta R, Nelson B, Chen D, Roenigk H. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol. 2000;42:690–2.

    PubMed  CAS  Google Scholar 

  57. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989–2003.

    Article  PubMed  CAS  Google Scholar 

  58. Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD, et al. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum. 2003;48:2585–92.

    Article  PubMed  CAS  Google Scholar 

  59. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35:35–42.

    Article  PubMed  CAS  Google Scholar 

  60. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581–90

    Google Scholar 

  61. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70:1068–76.

    Article  PubMed  CAS  Google Scholar 

  62. Costner MI, Grau RH. Update on connective tissue diseases in dermatology. Semin Cutan Med Surg. 2006;25:207–20.

    Article  PubMed  CAS  Google Scholar 

  63. Mayes MD. Classification and epidemiology of scleroderma. Semin Cutan Med Surg. 1998;17:22–6.

    Article  PubMed  CAS  Google Scholar 

  64. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol. 2006;33:263–8.

    PubMed  Google Scholar 

  65. Sontheimer RD. Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol. 2004;18:429–62.

    PubMed  CAS  Google Scholar 

  66. Halder RM, Roberts CI, Nootheti PK. Cutaneous diseases in the black races. Dermatol Clin. 2003;21:679–87.

    Article  PubMed  Google Scholar 

  67. Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg. 1998;17:48–54.

    Article  PubMed  CAS  Google Scholar 

  68. Ee HL, Tan SH. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol. 2005;30:131–3.

    Article  PubMed  CAS  Google Scholar 

  69. Adelowo OO, Oguntona S. Scleroderma (systemic sclerosis) among Nigerians. Clin Rheumatol. 2009;28:1121–5.

    Article  PubMed  CAS  Google Scholar 

  70. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001;30:332–46.

    Article  PubMed  CAS  Google Scholar 

  71. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger Jr TA, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum. 1999;42:465–74.

    Article  PubMed  CAS  Google Scholar 

  72. Mayes MD, Lacey Jr JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246–55.

    Article  PubMed  Google Scholar 

  73. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger Jr TA. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum. 1997;40:441–5.

    Article  PubMed  CAS  Google Scholar 

  74. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res. 1991;283:366–71.

    Article  PubMed  CAS  Google Scholar 

  75. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep. 2003;5:160–7.

    Article  PubMed  Google Scholar 

  76. Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger Jr TA. Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum. 2009;60:1112–8.

    Article  PubMed  Google Scholar 

  77. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest. 1998;114:801–7.

    Article  PubMed  CAS  Google Scholar 

  78. White B. Clinical approach to scleroderma. Semin Cutan Med Surg. 1998;17:213–8.

    Article  PubMed  CAS  Google Scholar 

  79. Pope JE, Shum DT, Gottschalk R, Stevens A, McManus R. Increased pigmentation in scleroderma. J Rheumatol. 1996;23:1912–6.

    PubMed  CAS  Google Scholar 

  80. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson Jr TL. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785–98.

    Article  PubMed  Google Scholar 

  81. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74:125–30.

    PubMed  Google Scholar 

  82. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000;61(2703–2710):2713–4.

    Google Scholar 

  83. Gupta AK, Nicol KA. Seborrheic dermatitis of the scalp: etiology and treatment. J Drugs Dermatol. 2004;3:155–8.

    PubMed  Google Scholar 

  84. Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48:S143–8.

    Article  PubMed  Google Scholar 

  85. Ogunbiyi AO, Daramola OO, Alese OO. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol. 2004;43:31–6.

    Article  PubMed  Google Scholar 

  86. Gupta AK, Madzia SE, Batra R. Etiology and management of Seborrheic dermatitis. Dermatology. 2004;208:89–93.

    Article  PubMed  Google Scholar 

  87. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1:75–80.

    Article  PubMed  CAS  Google Scholar 

  88. Brown DL, Frank JE. Diagnosis and management of syphilis. Am Fam Physician. 2003;68:283–90.

    PubMed  Google Scholar 

  89. Lautenschlager S. Cutaneous manifestations of syphilis: recognition and management. Am J Clin Dermatol. 2006;7:291–304.

    Article  PubMed  Google Scholar 

  90. Rosen T, Hwong H. Pedal interdigital condylomata lata: a rare sign of secondary syphilis. Sex Transm Dis. 2001;28:184–6.

    Article  PubMed  CAS  Google Scholar 

  91. Kent ME, Romanelli F. Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother. 2008;42:226–36.

    Article  PubMed  CAS  Google Scholar 

  92. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2007. Atlanta: U.S. Department of Health and Human Services; 2008.

    Google Scholar 

  93. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12:187–209.

    PubMed  CAS  Google Scholar 

  94. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis. 2007;44:1222–8.

    Article  PubMed  Google Scholar 

  95. Sunenshine PJ, Schwartz RA, Janniger CK. Tinea versicolor. Int J Dermatol. 1998;37:648–55.

    Article  PubMed  CAS  Google Scholar 

  96. Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis. 2006;19:139–47.

    Article  PubMed  Google Scholar 

  97. Mollet I, Ongenae K, Naeyaert JM. Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders. Dermatol Clin. 2007;25:363–71.

    Article  PubMed  CAS  Google Scholar 

  98. Gupta AK, Batra R, Bluhm R, Faergemann J. Pityriasis versicolor. Dermatol Clin. 2003;21:413–29.

    Article  PubMed  Google Scholar 

  99. Aljabre SH, Alzayir AA, Abdulghani M, Osman OO. Pigmentary changes of tinea versicolor in dark-skinned patients. Int J Dermatol. 2001;40:273–5.

    Article  PubMed  CAS  Google Scholar 

  100. Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, Abraham S, Rowell R. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007;6:1001–8.

    PubMed  Google Scholar 

  101. Warin AP. Hypochromic variant of pityriasis lichenoides chronic. Clin Exp Dermatol. 1978;3:85–7.

    Article  PubMed  CAS  Google Scholar 

  102. Clayton R, Warin A. Pityriasis lichenoides chronic presenting as hypopigmentation. Br J Dermatol. 1979;100:297–302.

    Article  PubMed  CAS  Google Scholar 

  103. Guillet G, Helenon R, Gauthier Y, Surleve-Bazeille JE, Plantin P, Sassolas BP. Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol. 1988;15:286–9.

    Article  PubMed  CAS  Google Scholar 

  104. MacKee GM, Wise W. White spot disease. J Cutan Dis. 1914;32:629–60.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Tulane University Health Science Center, New Orleans, LA, USA

    Kelli D. Grim M.D.

  2. Department of Dermatology, Baylor College of Medicine, 2815 Plumb Street, Houston, TX, 77005, USA

    Ted Rosen M.D.

Authors
  1. Kelli D. Grim M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ted Rosen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelli D. Grim M.D. .

Editor information

Editors and Affiliations

  1. Department of Dermatology, St. Luke’s Roosevelt Hospital, Skin of Color Center, New York, 10025, New York, USA

    Andrew F. Alexis

  2. Rush University, Department of Dermatology, Chicago, 60602, Illinois, USA

    Victoria H. Barbosa

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Grim, K.D., Rosen, T. (2013). Inflammatory Disorders with Unique Clinical Features. In: Alexis, A., Barbosa, V. (eds) Skin of Color. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84929-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-84929-4_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-84928-7

  • Online ISBN: 978-0-387-84929-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation